申请人:RAPTOR PHARMACEUTICALS INC.
公开号:US20170029376A1
公开(公告)日:2017-02-02
The present disclosure relates, in general, to compounds useful as inhibitors of fucosidase enzymes, and to methods and compositions for the treatment of tumors or cancers, such as liver disorders and liver tumors (e.g., hepatocellular carcinoma), with a compound as disclosed herein.